Nicolas Bosc
Overview
Explore the profile of Nicolas Bosc including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
18
Citations
990
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Akhoundi M, Bosc N, Benamari E, Brun S, Durand R, Izri A
Clin Exp Dermatol
. 2025 Mar;
PMID: 40063689
Delusional infestation syndrome (DI) is a rare psychiatric disorder characterized by a persistent, false belief of being infested by parasites. In this study, we evaluated the epidemiological and clinical characteristics...
2.
Adrien V, Bosc N, Peccia Galletto C, Diot T, Claverie D, Reggente N, et al.
J Med Internet Res
. 2024 May;
26:e58390.
PMID: 38742989
Posttraumatic stress disorder (PTSD) is a significant public health concern, with only a third of patients recovering within a year of treatment. While PTSD often disrupts the sense of body...
3.
Bosc N, Felix E, Gardner J, Mills J, Timmerman M, Asveld D, et al.
ACS Med Chem Lett
. 2023 Dec;
14(12):1733-1741.
PMID: 38116432
Efforts to tackle malaria must continue for a disease that threatens half of the global population. Parasite resistance to current therapies requires new chemotypes that are able to demonstrate effectiveness...
4.
Zdrazil B, Felix E, Hunter F, Manners E, Blackshaw J, Corbett S, et al.
Nucleic Acids Res
. 2023 Nov;
52(D1):D1180-D1192.
PMID: 37933841
ChEMBL (https://www.ebi.ac.uk/chembl/) is a manually curated, high-quality, large-scale, open, FAIR and Global Core Biodata Resource of bioactive molecules with drug-like properties, previously described in the 2012, 2014, 2017 and 2019...
5.
Sanz F, Pognan F, Steger-Hartmann T, Diaz C, Asakura S, Amberg A, et al.
Nat Rev Drug Discov
. 2023 Jun;
22(8):605-606.
PMID: 37316648
No abstract available.
6.
Adrien V, Bosc N, Fumat H, Tessier C, Ferreri F, Mouchabac S, et al.
Front Psychiatry
. 2023 Feb;
14:1089724.
PMID: 36816405
Schizophrenia is a severe, chronic, and heterogeneous mental disorder that affects approximately 1% of the world population. Ongoing research aims at clustering schizophrenia heterogeneity into various "biotypes" to identify subgroups...
7.
Briggs K, Bosc N, Camara T, Diaz C, Drew P, Drewe W, et al.
ALTEX
. 2021 Feb;
38(2):187-197.
PMID: 33637997
Pre-competitive data sharing can offer the pharmaceutical industry significant benefits in terms of reducing the time and costs involved in getting a new drug to market through more informed testing...
8.
Bosc N, Felix E, Arcila R, Mendez D, Saunders M, Green D, et al.
J Cheminform
. 2021 Feb;
13(1):13.
PMID: 33618772
Malaria is a disease affecting hundreds of millions of people across the world, mainly in developing countries and especially in sub-Saharan Africa. It is the cause of hundreds of thousands...
9.
Hunter F, Bento A, Bosc N, Gaulton A, Hersey A, Leach A
Chem Res Toxicol
. 2021 Jan;
34(2):385-395.
PMID: 33507738
The safety of marketed drugs is an ongoing concern, with some of the more frequently prescribed medicines resulting in serious or life-threatening adverse effects in some patients. Safety-related information for...
10.
Bosc N, Atkinson F, Felix E, Gaulton A, Hersey A, Leach A
J Cheminform
. 2021 Jan;
11(1):64.
PMID: 33430932
In response to Krstajic's letter to the editor concerning our published paper, we here take the opportunity to reply, to re-iterate that no errors in our work were identified, to...